-
IUPAC Name:{4-[(2S)-6-amino-2-[(2S)-2-(1-azido-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-amido)-3-phenylpropanamido]hexanamido]phenyl}methyl N-[3-({4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)propyl]carbamate
Supplier Lead time Price, $ Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: N3-PEG8-Phe-Lys-PABC-Gefitinib; Product Description: N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. N3-PEG8-Phe-Lys-PABC-Gefitinib is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.; Target: Drug-Linker Conjugates for ADCMedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: N3-PEG8-Phe-Lys-PABC-Gefitinib; Product Description: N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. N3-PEG8-Phe-Lys-PABC-Gefitinib is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.; Target: Drug-Linker Conjugates for ADCFor a custom pack size or bulk
please drop us a line:Enquire -
![]()
